JSR Corporation And KBI BioPharma Agree To Acquisition; INCJ And CMIC Of Japan Also Participate

SUNNYVALE, Calif. & TOKYO--(BUSINESS WIRE)--JSR Corporation (JSR), along with Tokyo-based CMIC Holdings Co. Ltd. (CMIC) and Innovation Network Corporation of Japan (INCJ), announced today that they have agreed to acquire KBI Biopharma, Inc., a biopharmaceutical contract development and manufacturing organization with facilities in Durham and Research Triangle Park, North Carolina and Boulder, Colorado. Following completion of the acquisition, JSR will own the majority interest in KBI within the acquiring group.

Help employers find you! Check out all the jobs and post your resume.